Role of ACE and ACE-2 in abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart

Authors

DOI:

https://doi.org/10.1590/s2175-97902022e19224%20%20

Keywords:

Ovariectomy, Captopril, Diminazene aceturate, Nitric oxide, Ischemic Preconditioning

Abstract

Ischemic heart disease is the leading cause of death in postmenopausal women. The activity of heart ACE increases whereas the activity of ACE-2 decreases after menopause. The present study was designed to investigate the role of ACE and ACE-2 in the abrogated cardioprotective effect of IPC in OVX rat heart. The heart was isolated from OVX rat and mounted on Langendorff’s apparatus for giving intermittent cycles of IPC. The infarct size was estimated using TTC stain, and coronary effluent was analyzed for LDH, CK-MB, and nitrite release. IPC induced cardioprotection was significantly attenuated in the ovariectomized rat heart as compared to the normal rat heart. However, this attenuated cardioprotection was significantly restored by perfusion of DIZE, an ACE-2 activator, and captopril, an ACE inhibitor, alone or in combination noted in terms of decrease in myocardial infarct size, the release of LDH and CK-MB, and also increase in the release of NO as compared to untreated OVX rat heart. Thus, it is suggested that DIZE and captopril, alone or in combination restore the attenuated cardioprotective effect of IPC in OVX rat heart which is due to an increase in ACE-2 activity and decrease in ACE activity after treatment.

Downloads

Download data is not yet available.

References

Abete P, Ferrara N, Cioppa A, Ferrara P, Bianco S, Calabrese C, et al. Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol. 1996;27(7):1777-1786.

Ajmani P, Yadav HN, Singh M, Sharma PL. Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. BMC Cardiovasc Disord. 2011;11:43.

Alderman MH. Renin Angiotensin system and the heart. Circulation. 2004;110:496-497.

Barrett-Connor E. Sex differences in coronary heart disease: why are women so superior? The 1995 ancel keys lecture. Circulation. 1997;95(1):252-264.

Baxter GF, Ebrahim Z. Role of bradykinin in preconditioning and protection of the ischaemic myocardium. Br J Pharmacol. 2002;135(4):843-854.

Brancaleone V, Bucci M. ACE­inhibition ameliorate vascular reactivity and delays diabetes outcome in NOD mice. Vascul Pharmacol. 2008;49(2-3):84-90.

Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors. Circulation. 1998;97(14):1411-1420.

Charan K, Goyal A, Gupta JK, Yadav HN. Role of atrial natriuretic peptide in ischemia preconditioning induced cardioprotection in the diabetic rat heart. J Surg Res. 2016;201(2):272-278.

Chopra K, Singh M, Kaul N. Decrease of myocardial infarct size with desferroxamine: possible role of oxygen free radicals in its ameliorative effect. Mol Cell Biochem. 1992;13(1):71-76.

Clarkson TB, Cline JM, Williams JK. Gonadal hormone substitutes: effects on cardiovascular system. Osteoporosis Int. 1997;7 (Suppl. 1):43-51.

Comini L, Bachetti T, Cargnoni A, Bastianon D. Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent. Pharmacol Res. 2007;56(1);42-48.

David ED, Kenneth MB. The cardiac renin-angiotensin system conceptual, or a regulator of cardiac function? Circ Res. 1999;85(7):643-650.

Degraeff PA, Delangen CDJ, Van Gikst WH, Bel K. Protective effect of captopril against ischemia/reperfusion- induced ventricular arrhythmias in vitro and in vivo. Am J Med. 1988;84(3):67-74.

Diz DI, Garcia-Espinosa MA, Gallagher PE. Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats. J Cardiovasc Pharmacol. 2008;51(6):542-548.

Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning and postconditioning. Pharmacol Rev. 2007;59(4):418-458.

Ferreira AJ, Santos RA, Almeida AP. Angiotensin-(1-7): cardioprotective effect in myocardial ischemic/reperfusion. Hypertension. 2001;38(3 Pt 2):665-668.

Fishbein MC, Meerbaum S, Rit J. Early phase acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981;101(5):593-600.

Fraga-Silva RA., Costa-Fraga FP, Montecucco F, Sturny M, Faye Y, Mach F, et al. Diminazene protect corpus cavernosum against hypercholesterolemia-induced injury. J Sex Med. 2015;12(2):289-302.

Garg K, Yadav HN, Singh M, Sharma PL. Mechanism of cardioprotective effect of erythropoietin-induced preconditioning in rat heart. Indian J Pharmacol. 2010;42(4):219-223.

Goyal A, Semwal BC, Yadav HN. Abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart. Hum Exp Toxicol. 2016;35(6):644-653.

Katovich MJ, Raizada MK. Diminazene aceturate enhances angiotensin-converting Enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Hypertension. 2013;62(4):746-752.

Kaur H, Parikh V, Sharma A. Effect of amiloride a Na+/H+ exchange inhibitor on cardioprotective effect of ischemic preconditioning: Possible involvement of resident cardiac mast cells. Pharmacol Res . 1997;36(2):95-102.

Klein HH, Pushman S, Schaper J. The mechanism of the tetrazolium reaction in identifying experimental infarction. Eur Soc Pathol, Virchows Archiv. 1981;393(3):287-297.

Langendorff O. Untersuchungen am uberlebenden saugethierherzen. Pflugers Arch Ges Physiol Mensch Tiere. 1895;61(6):291-332.

Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC. Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology. 2009;150(8):3753-3758.

Liu J, Kam KWL, Zhou JJ, Yan WY, Chen M, Wu S, et al. Effects of heat shock protein 70 activation by metabolic inhibition preconditioning or к- opioid receptor stimulation on Ca2+ homeostasis in rat ventricular myocytes subjected to ischemic insults. J Pharmacol Exp Ther. 2004;310(2):606-613.

Marletta MA, Yoon PS, Iyenger R. Macrophageoxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 1988;27(24):8706-8711.

Martinez LA, Molina RV. Early and chronic captopril or losarten therapy reduce infarct size and avoids congestive heart failure after myocardial infarction in rats. Arch Med Res. 2003;34(5):357-361.

Murray CE, Jenning JB, Reimer KA. Preconditioning with ischemic: a delay of lethal injury in ischemic myocardium. Circulation. 1986;74(5):1124-36.

Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet. 1997;349(9064):1498-1504.

Nachlas M and Schnitka C. Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am J Pathol. 1963;42(4):379-406.

Pereira IRO, Bertolami MC, and Faludi AA. Lipid peroxidation and nitric oxide inactivation in postmenopausal woman. Arq Bras Cardiol. 2013;80(4):406-423.

Pfeffer MA, Braunwald E, Moy LA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement study. N Engl J Med. 1992;327(10):669-677.

Piper HM, Abdullah Y, Schafer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res. 2004;61(3):365-371.

Prendes MGM, Gonzalez M, Savino EA, Varela A. Role of endogenous nitric oxide in classic preconditioning in rat hearts. Regul Pept. 2007;139(1-3):141-145.

Qi YF, Zhang J, Cole-Jeffrey CT, Shenoy V, Espejo A, Hanna M, et al. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Hypertension. 2013;62(4):746-752.

Sakima A, Averill DB, Gallagher PE. Impaired heart rate baroreflex in older rats: role of endogenous angiotensin-(1-7) at the nucleus tractus solitarii. Hypertension. 2005;46(2):333-340.

Sasaki H, Ogawa K, Shimizu M, Mori C, Takatsuka H, Okazaki F, et al. The insulin sensitizer pioglitazone improves the deterioration of ischemic preconditioning in Type 2 diabetes mellitus rats. Int Heart J. 2007;48(5):623-635.

Shinmura K, Nagai M, Tamaki K. Loss of ischemic preconditioning in ovariectomized rat hearts: possible involvement of impaired protein kinase C€ phosphorylation. Cardiovasc Res . 2008;79(3):387-394.

Singh VP, Le B, Khode R, Baker KM, Kumar R. Intracellular Angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes. 2008;57(12):3297-3306.

Skrzypiec-Spring M, Grotthus B, Szela A. Isolated heart perfusion according to langendorff-still viable in the new millennium. J Pharmacol Toxicol Methods. 2007;55(2):113-126.

Snoeckx LH, Vander Vuesse GJ, Coumans WA, Willemsen PH, Reneman RS. Differences in ischaemia tolerance between hypertrophied hearts of adult and aged spontaneously hypertensive rats. Cardiovasc Res . 1996;27(5):874-881.

Snoeckx LH, Vander Vusse GJ, Coumans WA, Willemsen PH, van der Nagel T, Reneman RS. Myocardial function in normal and spontaneously hypertensive rats during reperfusion after a period of global ischemia. Cardiovasc Res . 1986;20(1):67-75.

Stokoe D, Stephens LR, Copeland T, Gaffiney PR, Reese CB, Painter GF, et al. Dual role of phosphatidylinositol3,4,5 trisphosphate in the activation of protein kinase B. Science. 1997;277(5325):567-570.

Szabo C, Thiemermann C, and Vane JR. Dihydropyridine modulators of calcium channel inhibit the induction of nitric oxide synthase by endotoxin in cultured J774.2 cells. Biochem Biophys Res Commun. 1993;196(2):825-830.

Szabo C, Wu CC, Mitchell JA. Platelet activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res . 1993;73(6):991-999.

Tian Y, Li H, Liu P and Irwin MG. Captopril pretreatment produce an additive cardioprotective to isoflurane preconditioning in attenuating myocardial ischemic reperfusion injury in rabbits and in humans. Mediators Inflammation. 2015;1-12.

Topol EJ, Califf RM, Vandormael MA. Randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and angioplasty in myocardial infarction-6 study group. Circulation. 1992;85(6):2090-9.

Wang L, Cherednichenko G, Hernandez L. Preconditioning limits mitochondrial Ca 2+ during ischemia in rat hearts: Role of KATP channels. Am J Physiol Heart Circ Physiol. 2001;280(5):2321-2328.

Yadav HN, Singh M, Sharma PL. Involvement of GSK-3β in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. Mol Cell Biochem . 2010;343(1-2):75-81.

Zhang X, Xie YW, Nasjletti A, Bastianon D. ACE inhibitor promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation. 1997;95(1):176-182.

Downloads

Published

2022-11-23

Issue

Section

Original Article

How to Cite

Role of ACE and ACE-2 in abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart. (2022). Brazilian Journal of Pharmaceutical Sciences, 58. https://doi.org/10.1590/s2175-97902022e19224